Anti-LACRT functional antibody

Anti-LACRT functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to LACRT/LACRT products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1055-Ab-1/ GM-Tg-hg-SE1055-Ab-2Anti-Human LACRT monoclonal antibodyHuman
GM-Tg-rg-SE1055-Ab-1/ GM-Tg-rg-SE1055-Ab-2Anti-Rat LACRT monoclonal antibodyRat
GM-Tg-mg-SE1055-Ab-1/ GM-Tg-mg-SE1055-Ab-2Anti-Mouse LACRT monoclonal antibodyMouse
GM-Tg-cynog-SE1055-Ab-1/ GM-Tg-cynog-SE1055-Ab-2Anti-Cynomolgus/ Rhesus macaque LACRT monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1055-Ab-1/ GM-Tg-felg-SE1055-Ab-2Anti-Feline LACRT monoclonal antibodyFeline
GM-Tg-cang-SE1055-Ab-1/ GM-Tg-cang-SE1055-Ab-2Anti-Canine LACRT monoclonal antibodyCanine
GM-Tg-bovg-SE1055-Ab-1/ GM-Tg-bovg-SE1055-Ab-2Anti-Bovine LACRT monoclonal antibodyBovine
GM-Tg-equg-SE1055-Ab-1/ GM-Tg-equg-SE1055-Ab-2Anti-Equine LACRT monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1055-Ab-1/ GM-Tg-hg-SE1055-Ab-2; GM-Tg-rg-SE1055-Ab-1/ GM-Tg-rg-SE1055-Ab-2;
GM-Tg-mg-SE1055-Ab-1/ GM-Tg-mg-SE1055-Ab-2; GM-Tg-cynog-SE1055-Ab-1/ GM-Tg-cynog-SE1055-Ab-2;
GM-Tg-felg-SE1055-Ab-1/ GM-Tg-felg-SE1055-Ab-2; GM-Tg-cang-SE1055-Ab-1/ GM-Tg-cang-SE1055-Ab-2;
GM-Tg-bovg-SE1055-Ab-1/ GM-Tg-bovg-SE1055-Ab-2; GM-Tg-equg-SE1055-Ab-1/ GM-Tg-equg-SE1055-Ab-2
Products NameAnti-LACRT monoclonal antibody
Formatmab
Target NameLACRT
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LACRT benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1055-Ag-1Recombinant multi-species LACRT protein
    ORF Viral VectorvGMLP000148human LACRT Lentivirus particle
    ORF Viral VectorpGMLP000148human LACRT Lentivirus plasmid


    Target information

    Target IDGM-SE1055
    Target NameLACRT
    Gene ID90070,654418,100687562,102901478
    Gene Symbol and SynonymsLACRT
    Uniprot AccessionQ9GZZ8
    Uniprot Entry NameLACRT_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000135413
    Target ClassificationN/A

    The target: LACRT, gene name: LACRT, also named as . The protein encoded by this gene is highly expressed in the lacrimal glands and localized primarily to secretory granules and secretory fluid. It augments lacrimal acinar cell secretion, promotes ductal cell proliferation, and stimulates signaling through tyrosine phosphorylation and release of calcium. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.